 |
市場調査レポート
商品コード
1178049
色素沈着過剰障害治療の世界市場：治療タイプ別（コスメシューティカルズ、レーザー治療、ケミカルピーリング、マイクロダーマブレーション、光線療法、その他）－業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年）Hyperpigmentation Disorder Treatment Market (Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion, Phototherapy, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 色素沈着過剰障害治療の世界市場：治療タイプ別（コスメシューティカルズ、レーザー治療、ケミカルピーリング、マイクロダーマブレーション、光線療法、その他）－業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年） |
|
出版日: 2022年11月01日
発行: Transparency Market Research
ページ情報: 英文 113 Pages
納期: 2～10営業日
|
- 全表示
- 概要
- 図表
- 目次
概要
当レポートでは、世界の色素沈着過剰障害治療市場について調査分析し、市場概要、市場分析、競合情勢など、体系的な情報を提供しています。
目次
第1章 序文
第2章 前提と調査手法
第3章 エグゼクティブサマリー：世界の色素沈着過剰障害治療市場
第4章 市場概要
- イントロダクション
- 定義
- 業界の進化/発展
- 概要
- 市場力学
- 促進要因
- 抑制要因
- 機会
- 世界の色素沈着過剰障害治療市場の分析と予測（2017年～2031年）
第5章 主な洞察
- 主要な市場動向
- 合併と買収
- 市場で活動する主要5企業の戦略
- 整形外科疾患の発生率：主要国別
- 規制および償還シナリオ：主要国別
第6章 世界の色素沈着過剰障害治療市場の分析と予測：治療タイプ別
- イントロダクションと定義
- 市場金額予測（2017年～2031年）：治療タイプ別
- コスメシューティカルズ
- レーザー治療
- ケミカルピーリング
- マイクロダーマブレーション
- 光線療法
- その他
- 市場の魅力：治療タイプ別
第7章 世界の色素沈着過剰障害治療市場の分析と予測：適応症別
- イントロダクションと定義
- 市場金額予測（2017年～2031年）：適応症別
- 肝斑
- 炎症後色素沈着
- 日光黒子
- その他
- 市場魅力分析：適応症別
第8章 世界の色素沈着過剰障害治療市場の分析と予測：エンドユーザー別
- イントロダクションと定義
- 市場金額予測（2017年～2031年）：エンドユーザー別
- 病院
- エステ・皮膚科
- その他
- 市場魅力分析：エンドユーザー別
第9章 世界の色素沈着過剰障害治療市場の分析と予測：地域別
- 主な調査結果
- 市場金額予測：地域別
- 北米
- 欧州
- アジア太平洋地域
- ラテンアメリカ
- 中東・アフリカ
- 市場魅力分析：地域別
第10章 北米の色素沈着過剰障害治療市場の分析と予測
第11章 欧州の色素沈着過剰障害治療市場の分析と予測
第12章 アジア太平洋の色素沈着過剰障害治療市場の分析と予測
第13章 ラテンアメリカの色素沈着過剰障害治療市場の分析と予測
第14章 中東およびアフリカの色素沈着過剰障害治療市場の分析と予測
第15章 競合情勢
- 市場参入企業－競合マトリックス（層と企業規模別）
- 市場シェア分析（2021年）：企業別
- 企業プロファイル
- Aerolase Corporation
- Candela Corporation
- Cynosure
- Galderma SA
- iSCLINICAL
- ISDIN
- L'Oreal（SkinCeuticals, Skinbetterscience &La Roche-Posay）
- Lumenis Be Ltd.
- Mesoestetics
- Obagi Cosmeceuticals LLC
- PCA Skin
- Scientis
- Sente Labs
- SkinMedica（AbbVie）
- ZO Skin Health, Inc.
図表
List of Tables
- Table 01: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
- Table 02: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
- Table 03: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
- Table 04: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Region, 2017-2031
- Table 05: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country, 2017-2031
- Table 06: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
- Table 07: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
- Table 08: North America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
- Table 09: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 10: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
- Table 11: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
- Table 12: Europe Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
- Table 13: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 14: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
- Table 15: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
- Table 16: Asia Pacific Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
- Table 17: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 18: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
- Table 19: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
- Table 20: Latin America Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
- Table 21: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 22: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2017-2031
- Table 23: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by Disease Indication, 2017-2031
- Table 24: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
- Figure 01: Global Hyperpigmentation Disorder Treatment Market Size (US$ Mn) and Distribution (%), by Region, 2018 and 2031
- Figure 02: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn), by Treatment Type, 2021
- Figure 03: Global Hyperpigmentation Disorder Treatment Market Value Share, by Treatment Type, 2021
- Figure 04: Global Hyperpigmentation Disorder Treatment Market Value Share, by Disease Indication, 2021
- Figure 05: Global Hyperpigmentation Disorder Treatment Market Value Share, by End-user, 2021
- Figure 06: Global Hyperpigmentation Disorder Treatment Market Value Share, by Region, 2021
- Figure 07: Global Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast, 2017-2031
- Figure 08: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
- Figure 09: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Phototherapy, 2017-2031
- Figure 10: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmeceuticals, 2017-2031
- Figure 11: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chemical Peels, 2017-2031
- Figure 12: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Microdermabrasion, 2017-2031
- Figure 13: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Laser Therapy, 2017-2031
- Figure 14: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
- Figure 15: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
- Figure 16: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
- Figure 17: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Melasma, 2017-2031
- Figure 18: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-inflammatory Hyperpigmentation, 2017-2031
- Figure 19: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Restorative Surgery, 2017-2031
- Figure 20: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
- Figure 21: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
- Figure 22: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 23: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
- Figure 24: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Esthetic Clinics & Dermatology Centers, 2017-2031
- Figure 25: Global Hyperpigmentation Disorder Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
- Figure 26: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
- Figure 27: Global Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Region, 2017 and 2031
- Figure 28: Global Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Region, 2022-2031
- Figure 29: North America Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 30: North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country, 2017-2031
- Figure 31: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country, 2017 and 2031
- Figure 32: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
- Figure 33: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
- Figure 34: North America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 35: North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
- Figure 36: North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
- Figure 37:North America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
- Figure 38: Europe Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 39: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 40: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 41: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
- Figure 42: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
- Figure 43: Europe Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 44: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
- Figure 45: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
- Figure 46: Europe Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
- Figure 47: Asia Pacific Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 48: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 49: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 50: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
- Figure 51: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
- Figure 52: Asia Pacific Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 53: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
- Figure 54: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
- Figure 55: Asia Pacific Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
- Figure 56: Latin America Hyperpigmentation Disorder Treatment Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 57: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 58: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 59: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
- Figure 60: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
- Figure 61: Latin America Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 62: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
- Figure 63: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
- Figure 64: Latin America Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
- Figure 65: Middle East & Africa Hyperpigmentation Disorder Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
- Figure 66: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
- Figure 67: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Country/Sub-region, 2017 and 2031
- Figure 68: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Treatment Type, 2017 and 2031
- Figure 69: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by Disease Indication, 2017 and 2031
- Figure 70: Middle East & Africa Hyperpigmentation Disorder Treatment Market Value Share Analysis, by End-user, 2017 and 2031
- Figure 71: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Treatment Type, 2022-2031
- Figure 72: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by Disease Indication, 2022-2031
- Figure 73: Middle East & Africa Hyperpigmentation Disorder Treatment Market Attractiveness Analysis, by End-user, 2022-2031
目次
Product Code: TMRGL46644
TMR's report on the global hyperpigmentation disorder treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global hyperpigmentation disorder treatment market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hyperpigmentation disorder treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hyperpigmentation disorder treatment market.
The report delves into the competitive landscape of the global hyperpigmentation disorder treatment market. Key players operating in the global hyperpigmentation disorder treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global hyperpigmentation disorder treatment market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hyperpigmentation Disorder Treatment Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Key Market Trends
- 5.2. Merger and Acquisition
- 5.3. Strategies of Top Five Players Operating in the Market
- 5.4. Incidence of Orthopedic Disorder, by Key Countries
- 5.5. Regulatory and Reimbursement Scenario, by Key Countries
6. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by Treatment Type
- 6.1. Introduction & Definition
- 6.2. Market Value Forecast, by Treatment Type, 2017-2031
- 6.2.1. Cosmeceuticals
- 6.2.2. Laser Therapy
- 6.2.3. Chemical Peels
- 6.2.4. Microdermabrasion
- 6.2.5. Phototherapy
- 6.2.6. Others
- 6.3. Market Attractiveness, by Treatment Type
7. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by Disease Indication
- 7.1. Introduction & Definition
- 7.2. Market Value Forecast, by Disease Indication, 2017-2031
- 7.2.1. Melasma
- 7.2.2. Post-inflammatory Hyperpigmentation
- 7.2.3. Solar Lentigines
- 7.2.4. Others
- 7.3. Market Attractiveness Analysis, by Disease Indication
8. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by End-user
- 8.1. Introduction & Definition
- 8.2. Market Value Forecast, by End-user, 2017-2031
- 8.2.1. Hospitals
- 8.2.2. Esthetic Clinics & Dermatology Centers
- 8.2.3. Others
- 8.3. Market Attractiveness Analysis, by End-user
9. Global Hyperpigmentation Disorder Treatment Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Hyperpigmentation Disorder Treatment Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Treatment Type, 2017-2031
- 10.2.1. Cosmeceuticals
- 10.2.2. Laser Therapy
- 10.2.3. Chemical Peels
- 10.2.4. Microdermabrasion
- 10.2.5. Phototherapy
- 10.2.6. Others
- 10.3. Market Value Forecast, by Disease Indication, 2017-2031
- 10.3.1. Melasma
- 10.3.2. Post-inflammatory Hyperpigmentation
- 10.3.3. Solar Lentigines
- 10.3.4. Others
- 10.4. Market Value Forecast, by End-user, 2017-2031
- 10.4.1. Hospitals
- 10.4.2. Esthetic Clinics & Dermatology Centers
- 10.4.3. Others
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Treatment Type
- 10.6.2. By Disease Indication
- 10.6.3. By End-user
- 10.6.4. By Country
11. Europe Hyperpigmentation Disorder Treatment Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Treatment Type, 2017-2031
- 11.2.1. Cosmeceuticals
- 11.2.2. Laser Therapy
- 11.2.3. Chemical Peels
- 11.2.4. Microdermabrasion
- 11.2.5. Phototherapy
- 11.2.6. Others
- 11.3. Market Value Forecast, by Disease Indication, 2017-2031
- 11.3.1. Melasma
- 11.3.2. Post-inflammatory Hyperpigmentation
- 11.3.3. Solar Lentigines
- 11.3.4. Others
- 11.4. Market Value Forecast, by End-user, 2017-2031
- 11.4.1. Hospitals
- 11.4.2. Esthetic Clinics & Dermatology Centers
- 11.4.3. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Treatment Type
- 11.6.2. By Disease Indication
- 11.6.3. By End-user
- 11.6.4. By Country/Sub-region
12. Asia Pacific Hyperpigmentation Disorder Treatment Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Treatment Type, 2017-2031
- 12.2.1. Cosmeceuticals
- 12.2.2. Laser Therapy
- 12.2.3. Chemical Peels
- 12.2.4. Microdermabrasion
- 12.2.5. Phototherapy
- 12.2.6. Others
- 12.3. Market Value Forecast, by Disease Indication, 2017-2031
- 12.3.1. Melasma
- 12.3.2. Post-inflammatory Hyperpigmentation
- 12.3.3. Solar Lentigines
- 12.3.4. Others
- 12.4. Market Value Forecast, by End-user, 2017-2031
- 12.4.1. Hospitals
- 12.4.2. Esthetic Clinics & Dermatology Centers
- 12.4.3. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Treatment Type
- 12.6.2. By Disease Indication
- 12.6.3. By End-user
- 12.6.4. By Country/Sub-region
13. Latin America Hyperpigmentation Disorder Treatment Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Treatment Type, 2017-2031
- 13.2.1. Cosmeceuticals
- 13.2.2. Laser Therapy
- 13.2.3. Chemical Peels
- 13.2.4. Microdermabrasion
- 13.2.5. Phototherapy
- 13.2.6. Others
- 13.3. Market Value Forecast, by Disease Indication, 2017-2031
- 13.3.1. Melasma
- 13.3.2. Post-inflammatory Hyperpigmentation
- 13.3.3. Solar Lentigines
- 13.3.4. Others
- 13.4. Market Value Forecast, by End-user, 2017-2031
- 13.4.1. Hospitals
- 13.4.2. Esthetic Clinics & Dermatology Centers
- 13.4.3. Others
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Treatment Type
- 13.6.2. By Disease Indication
- 13.6.3. By End-user
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Hyperpigmentation Disorder Treatment Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Treatment Type, 2017-2031
- 14.2.1. Cosmeceuticals
- 14.2.2. Laser Therapy
- 14.2.3. Chemical Peels
- 14.2.4. Microdermabrasion
- 14.2.5. Phototherapy
- 14.2.6. Others
- 14.3. Market Value Forecast, by Disease Indication, 2017-2031
- 14.3.1. Melasma
- 14.3.2. Post-inflammatory Hyperpigmentation
- 14.3.3. Solar Lentigines
- 14.3.4. Others
- 14.4. Market Value Forecast, by End-user, 2017-2031
- 14.4.1. Hospitals
- 14.4.2. Esthetic Clinics & Dermatology Centers
- 14.4.3. Others
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Treatment Type
- 14.6.2. By Disease Indication
- 14.6.3. By End-user
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competitive Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company (2021)
- 15.3. Company Profiles
- 15.3.1. Aerolase Corporation
- 15.3.1.1. Company Overview
- 15.3.1.2. Treatment Type Portfolio
- 15.3.1.3. SWOT Analysis
- 15.3.1.4. Financial Overview
- 15.3.1.5. Strategic Overview
- 15.3.2. Candela Corporation
- 15.3.2.1. Company Overview
- 15.3.2.2. Treatment Type Portfolio
- 15.3.2.3. SWOT Analysis
- 15.3.2.4. Financial Overview
- 15.3.2.5. Strategic Overview
- 15.3.3. Cynosure
- 15.3.3.1. Company Overview
- 15.3.3.2. Treatment Type Portfolio
- 15.3.3.3. SWOT Analysis
- 15.3.3.4. Financial Overview
- 15.3.4. Galderma S.A.
- 15.3.4.1. Company Overview
- 15.3.4.2. Treatment Type Portfolio
- 15.3.4.3. SWOT Analysis
- 15.3.4.4. Financial Overview
- 15.3.4.5. Strategic Overview
- 15.3.5. iSCLINICAL
- 15.3.5.1. Company Overview
- 15.3.5.2. Treatment Type Portfolio
- 15.3.5.3. SWOT Analysis
- 15.3.5.4. Financial Overview
- 15.3.5.5. Strategic Overview
- 15.3.6. ISDIN
- 15.3.6.1. Company Overview
- 15.3.6.2. Treatment Type Portfolio
- 15.3.6.3. SWOT Analysis
- 15.3.7. L'Oreal (SkinCeuticals, Skinbetterscience & La Roche-Posay)
- 15.3.7.1. Company Overview
- 15.3.7.2. Treatment Type Portfolio
- 15.3.7.3. SWOT Analysis
- 15.3.7.4. Strategic Overview
- 15.3.8. Lumenis Be Ltd.
- 15.3.8.1. Company Overview
- 15.3.8.2. Treatment Type Portfolio
- 15.3.8.3. SWOT Analysis
- 15.3.8.4. Strategic Overview
- 15.3.9. Mesoestetics
- 15.3.9.1. Company Overview
- 15.3.9.2. Treatment Type Portfolio
- 15.3.9.3. SWOT Analysis
- 15.3.9.4. Financial Overview
- 15.3.9.5. Strategic Overview
- 15.3.10. Obagi Cosmeceuticals LLC
- 15.3.10.1. Company Overview
- 15.3.10.2. Treatment Type Portfolio
- 15.3.10.3. SWOT Analysis
- 15.3.10.4. Financial Overview
- 15.3.10.5. Strategic Overview
- 15.3.11. PCA Skin
- 15.3.11.1. Company Overview
- 15.3.11.2. Treatment Type Portfolio
- 15.3.11.3. SWOT Analysis
- 15.3.11.4. Financial Overview
- 15.3.11.5. Strategic Overview
- 15.3.12. Scientis
- 15.3.12.1. Company Overview
- 15.3.12.2. Treatment Type Portfolio
- 15.3.12.3. SWOT Analysis
- 15.3.12.4. Financial Overview
- 15.3.12.5. Strategic Overview
- 15.3.13. Sente Labs
- 15.3.13.1. Company Overview
- 15.3.13.2. Treatment Type Portfolio
- 15.3.13.3. SWOT Analysis
- 15.3.13.4. Financial Overview
- 15.3.13.5. Strategic Overview
- 15.3.14. SkinMedica (AbbVie)
- 15.3.14.1. Company Overview
- 15.3.14.2. Treatment Type Portfolio
- 15.3.14.3. SWOT Analysis
- 15.3.14.4. Financial Overview
- 15.3.14.5. Strategic Overview
- 15.3.15. ZO Skin Health, Inc.
- 15.3.15.1. Company Overview
- 15.3.15.2. Treatment Type Portfolio
- 15.3.15.3. SWOT Analysis
- 15.3.15.4. Financial Overview
- 15.3.15.5. Strategic Overview
- 15.3.1. Aerolase Corporation
